Evidence map›Paper›PMID 23202492›Full record

ReviewViruses2012

MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.

Archana Gupta, Gokul Swaminathan, Julio Martin-Garcia, Sonia Navas-Martin

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The involvement of microRNAs in HCV and HIV infection.Therapeutic advances in vaccines and immunotherapy · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Article
  15. Regulation of cancer metastasis by microRNAs.Journal of biomedical science · 2015
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. MicroRNAs in Liver Disease: Bench to Bedside.Journal of clinical and experimental hepatology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Archana GuptaDepartment of Microbiology and Immunology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, USA. ag434@drexel.edu
Gokul Swaminathan
Julio Martin-Garcia
Sonia Navas-Martin
Drexel University · US

Funding

Brain HIV-1 isolates/envelopes: CD4 dependence, fusogenicity and neurotoxicityR01NS065727 · NINDS · DREXEL UNIVERSITY · PI MARTIN-GARCIA, JULIO · 2009 to 2013
$2.1M
Coronavirus modulation of cellular microRNAs in the liver: role in hepatitisR21DK089314 · NIDDK · DREXEL UNIVERSITY · PI NAVAS-MARTIN, SONIA · 2011 to 2012
$425k
Role of microRNAs in Coronavirus-induced lethal encephalitisR21AI088423 · NIAID · DREXEL UNIVERSITY · PI NAVAS-MARTIN, SONIA · 2011 to 2012
$425k
miR-155 regulation of cellular susceptibility to HIV-1 infectionR21AI098549 · NIAID · DREXEL UNIVERSITY · PI MARTIN-GARCIA, JULIO · 2012 to 2013
$413k
Role of toll-like receptors 2 and 3 in coronavirus-induced encephalitisR03NS061179 · NINDS · DREXEL UNIVERSITY · PI NAVAS-MARTIN, SONIA · 2010 to 2011
$152k
NIAID NIH HHS AI088423NIAID NIH HHS AI098549NIAID NIH HHS R21 AI088423NIAID NIH HHS R21 AI098549NIDDK NIH HHS DK089314NIDDK NIH HHS R21 DK089314NINDS NIH HHS NS061179NINDS NIH HHS NS065727NINDS NIH HHS R01 NS065727NINDS NIH HHS R03 NS061179
6 · The paper itself

Abstract

MicroRNAs (miRNAs) can exert a profound effect on Hepatitis C virus (HCV) replication. The interaction of HCV with the highly liver-enriched miRNA, miR-122 represents one such unique example of viruses having evolved mechanism(s) to usurp the host miRNA machinery to support viral life cycle. Furthermore, HCV infection can also trigger changes in the cellular miRNA profile, which may ultimately contribute to the outcome of viral infection. Accumulating knowledge on HCV-host miRNA interactions has ultimately influenced the design of therapeutic interventions against chronic HCV infection. The importance of microRNA modulation in Human Immunodeficiency Virus (HIV-1) replication has been reported, albeit only in the context of HIV-1 mono-infection. The development of HCV infection is dramatically influenced during co-infection with HIV-1. Here, we review the current knowledge on miRNAs in HCV mono-infection. In addition, we discuss the potential role of some miRNAs, identified from the analyses of public data, in HCV/HIV-1 co-infection.

Indexed as

CoinfectionHepacivirusHepatitis CHIV-1HIV InfectionsHumansMicroRNAsMicroRNAs

Identifiers

PMID23202492
PMCPMC3509660
OpenAlexW2052560162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.